Leflunomide
Online Access:
Subscribe
This is a drug monograph from the BSAVA Small Animal Formulary Part A: Canine and Feline. BSAVA members should login for access to the full monograph. Non-members can join BSAVA, buy a Formulary subscription, or buy the printed edition.
-
Affolter VK and Moore PF (2000) Canine cutaneous and systemic histiocytosis: reactive histiocytosis of dermal dendritic cells. American Journal of Dermatopathology 22, 40–48
-
Chesne RB, Doornink MT, Sri-Jayantha LSH and Urie BK (2024) Leflunomide with prednisone or nonsteroidal anti-inflammatory drug therapy is safe and tolerated for long-term treatment of immune-mediated polyarthritis in 27 dogs. Journal of the American Veterinary Medical Association 262, 1188–1192
-
Colopy SA, Baker TA and Muir P (2010) Efficacy of leflunomide for treatment of immune-mediated polyarthritis in dogs: 14 cases (2006–2008). Journal of the American Veterinary Medical Association 236, 312–318
-
Gregory CR, Stewart A, Sturges B et al. (1998) Leflunomide effectively treats naturally occurring immune-mediated and inflammatory diseases of dogs that are unresponsive to conventional therapy. Transplant Proceedings 30, 4143–4148
-
Mehl ML, Tell L, Kyles AE et al. (2012) Pharmacokinetics and pharmacodynamics of A77 1726 and leflunomide in domestic cats. Journal of Veterinary Pharmacology and Therapeutics 35, 139–146
-
Sato M, Veir JK, Legare M and Lappin MR (2017) A retrospective study on the safety and efficacy of leflunomide in dogs. Journal of Veterinary Internal Medicine 31,1502–1507
-
Wilson R, Swift I, Groth-Semple M et al. (2024) Treatment with leflunomide in conjunction with glucocorticoids for dogs with immune-mediated polyarthritis is not associated with improved outcomes: A retrospective cohort study of 93 dogs from Australia (2017-2024). Veterinary Sciences 11, 537